Sue Ann Costa Clemens1, Calil Kairalla Farhat. 1. Departamento de Metodologia da Pesquisa, Instituto de Pós-Graduação Médica Carlos Chagas, Rio de Janeiro, RJ, Brasil. clemens.r.sac@terra.com.br
Abstract
OBJECTIVE: To estimate the seroprevalence of HSV-1 and HSV-2 antibodies in Brazil and to analyze factors associated. METHODS: Cross-sectional study including subjects aged 1-40 years from the general population in four different geographical areas in Brazil between 1996 and 1997. All subjects were stratified by age and gender and 1,090 of them were included in the final analysis. Blood samples were tested for HSV-1 and HSV-2 antibodies by type-specific (gG1 and gG2) ELISA. Frequencies and proportions were described and compared among groups using two-sided Fisher's exact test. A logistic regression analysis was performed to assess the influence of the variables age, gender, geographical area, socioeconomic condition, past history of STD, seropositivity for anti-HSV-1 or anti-HSV-2 and interactions of any of these factors on the seroprevalence of HSV-1 and/or HSV-2. RESULTS: The age-adjusted seroprevalences of HSV-1 and HSV-2 antibodies were 67.2% and 11.3%, respectively, without sex differences and being higher in the North region. Seroprevalences increased with age and, for HSV-2 infection, the higher increase was observed among adolescents and young adults. Subjects who tested positive for HSV-1 were more likely to also test positive for HSV-2 (15.7%) compared to HSV-1 negative subjects (4.7%). In the multivariate analysis past history of STD significantly (OR=3.2) increased the likelihood of HSV-2 infection whereas socioeconomic condition did not affect the results. CONCLUSIONS: HSV-1 and HSV-2 seroprevalences vary with age and among Brazilian regions. Past history of STD is a major risk factor for HSV-2 infection.
OBJECTIVE: To estimate the seroprevalence of HSV-1 and HSV-2 antibodies in Brazil and to analyze factors associated. METHODS: Cross-sectional study including subjects aged 1-40 years from the general population in four different geographical areas in Brazil between 1996 and 1997. All subjects were stratified by age and gender and 1,090 of them were included in the final analysis. Blood samples were tested for HSV-1 and HSV-2 antibodies by type-specific (gG1 and gG2) ELISA. Frequencies and proportions were described and compared among groups using two-sided Fisher's exact test. A logistic regression analysis was performed to assess the influence of the variables age, gender, geographical area, socioeconomic condition, past history of STD, seropositivity for anti-HSV-1 or anti-HSV-2 and interactions of any of these factors on the seroprevalence of HSV-1 and/or HSV-2. RESULTS: The age-adjusted seroprevalences of HSV-1 and HSV-2 antibodies were 67.2% and 11.3%, respectively, without sex differences and being higher in the North region. Seroprevalences increased with age and, for HSV-2 infection, the higher increase was observed among adolescents and young adults. Subjects who tested positive for HSV-1 were more likely to also test positive for HSV-2 (15.7%) compared to HSV-1 negative subjects (4.7%). In the multivariate analysis past history of STD significantly (OR=3.2) increased the likelihood of HSV-2 infection whereas socioeconomic condition did not affect the results. CONCLUSIONS:HSV-1 and HSV-2 seroprevalences vary with age and among Brazilian regions. Past history of STD is a major risk factor for HSV-2 infection.
Authors: J F M Almeida; A H Campos; M A Marcello; N E Bufalo; C L Rossi; L H P Amaral; A B Marques; L L Cunha; C A Alvarenga; P C Tincani; A J Tincani; L S Ward Journal: J Endocrinol Invest Date: 2017-03-08 Impact factor: 4.256
Authors: Adriana A Pinho; Magda Chinaglia; Sheri A Lippman; Arthur Reingold; Ricardo Sobhie Diaz; Maria Cecilia Sucupira; Kimberly Page; Juan Díaz Journal: Sex Transm Infect Date: 2011-10-03 Impact factor: 3.519
Authors: Andreza Veruska Lira Correia; Maria Rosângela Cunha Duarte Coêlho; Georgea Gertrudes de Oliveira Mendes Cahú; Jéfferson Luis de Almeida Silva; Catarina da Mota Vasconcelos Brasil; Jurema Freire Lisboa de Castro Journal: Support Care Cancer Date: 2014-12-30 Impact factor: 3.603
Authors: Amanda Perse da Silva; Amanda de Oliveira Lopes; Yasmine Rangel Vieira; Adilson José de Almeida; Fernando Samuel Sion; Beatriz Grinsztejn; Sandra Wagner; Vanessa Salete de Paula Journal: PLoS One Date: 2015-09-25 Impact factor: 3.240
Authors: F T G S Cardozo; I V Larsen; E V Carballo; G Jose; R A Stern; R C Brummel; C M Camelini; M J Rossi; C M O Simões; C R Brandt Journal: Antimicrob Agents Chemother Date: 2013-03-18 Impact factor: 5.191
Authors: S Rezaei-Chaparpordi; M Assmar; N Amirmozafari; L Modiri; A Massiha; S Shokri-Fashtali; Z Gholizadeh; S Akbari Journal: Iran J Public Health Date: 2012-08-31 Impact factor: 1.429
Authors: Thaís Duquia Moraes Caldeira; Carla Vitola Gonçalves; Gisele Rodrigues de Oliveira; Tânia Vieira da Fonseca; Regina Gonçalves; Clair Teixeira do Amaral; Vanusa Pousada da Hora; Ana Maria Barral de Martinez Journal: Rev Inst Med Trop Sao Paulo Date: 2013 Sep-Oct Impact factor: 1.846